Please perform the following steps or contact us any time:
Step 1: Please request the European ScreeningPort Confidential Disclosure Agreement (CDA). Upon receipt European ScreeningPort will:

• reply within 1 working day to confirm arrival of the CDA
• provide a signed hard copy for your records
• provide guidance and informal advice on funding options, as required

Step 2: Complete and return the Project Description Document*. This captures:

• contact details of the principle scientists and institutions involved 
• scientific background of the target and evidence for therapeutic relevance
• key project aspirations
• preferred funding model

Step 3: (optional) Complete and return the Reagent and Bioassay Design Document* to European ScreeningPort. This captures:

• the reagent design and production process for the target protein
• planned approach (HTS, fragment approaches, etc)
• proposed bioassay protocols (include primary, confirmation and selectivity if known)
• identity of tool and control compounds

European ScreeningPort will support you at any of these steps to identify the key features of the project and to discuss the next steps.

*Please contact contact(at)screeningport.com and we will send you these documents.